Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Adopts Shareholder Plan as Protection in Event of Takeover Bid

NEW YORK, May 22 - Orchid BioSciences said Tuesday it has adopted a stockholder rights plan in an effort to protect the company in the event of a hostile takeover attempt.

Over the past few months several companies, including Aclara,  Large Scale Biology, and Illumina , have adopted such plans amid falling stock prices.

The stockholder rights plans work by allowing current shareholders the right to buy additional stock in the company at an artificially low price, in the event a third party acquires more than a certain percentage of the company’s stock. The action in effect dilutes the stock, reducing the stake of the potential acquirer.

Under the terms of Orchid’s rights plan, rights holders would be entitled to buy common stock at a significant discount to the stock price should any person or group attempting to takeover the company acquire 15 percent or more of Orchid’s common stock.

In effect, this is designed to discourage the acquisition of 15 percent or more of the company’s common stock without negotiations with its board of directors.

Orchid of Princeton, NJ, said it did not implement the plan in response to any particular offer or takeover attempt.

Orchid’s share price was down $1.05, or 13 percent, at $7.30 in morning trading Tuesday following a steep run up in the price over the past week.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.